Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World

NCT03636984 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Ankylosing Spondylitis

Interventions

DRUG: recombinant TNF-α receptor: IgG Fc fusion protein

Sponsor

Zhejiang Hisun Pharmaceutical Co. Ltd.